254 related articles for article (PubMed ID: 37138341)
21. Risk of subsequent myeloid neoplasms after radiotherapy treatment for a solid cancer among adults in the United States, 2000-2014.
Teepen JC; Curtis RE; Dores GM; Berrington de Gonzalez A; van den Heuvel-Eibrink MM; Kremer LCM; Gilbert ES; van Leeuwen FE; Ronckers CM; Morton LM
Leukemia; 2018 Dec; 32(12):2580-2589. PubMed ID: 29795414
[TBL] [Abstract][Full Text] [Related]
22. Risk of primary haematologic cancers following incident non-metastatic breast cancer: A Danish population-based cohort study.
Hjorth CF; Farkas DK; Schapira L; Cullen MR; Sørensen HT; Cronin-Fenton D
Cancer Epidemiol; 2023 Feb; 82():102311. PubMed ID: 36508968
[TBL] [Abstract][Full Text] [Related]
23. Bone and Soft-Tissue Sarcoma Risk in Long-Term Survivors of Hereditary Retinoblastoma Treated With Radiation.
Kleinerman RA; Schonfeld SJ; Sigel BS; Wong-Siegel JR; Gilbert ES; Abramson DH; Seddon JM; Tucker MA; Morton LM
J Clin Oncol; 2019 Dec; 37(35):3436-3445. PubMed ID: 31622129
[TBL] [Abstract][Full Text] [Related]
24. The impact of in situ breast cancer and family history on risk of subsequent breast cancer events and mortality - a population-based study from Sweden.
Sackey H; Hui M; Czene K; Verkooijen H; Edgren G; Frisell J; Hartman M
Breast Cancer Res; 2016 Oct; 18(1):105. PubMed ID: 27756431
[TBL] [Abstract][Full Text] [Related]
25. Mutual Risks of Cutaneous Melanoma and Specific Lymphoid Neoplasms: Second Cancer Occurrence and Survival.
Herr MM; Schonfeld SJ; Dores GM; Withrow DR; Tucker MA; Curtis RE; Morton LM
J Natl Cancer Inst; 2018 Nov; 110(11):1248-1258. PubMed ID: 29659938
[TBL] [Abstract][Full Text] [Related]
26. Risk of Second Primary Female Genital Malignancies in Women with Breast Cancer: a SEER Analysis.
Li Z; Wu Q; Song J; Zhang Y; Zhu S; Sun S
Horm Cancer; 2018 Jun; 9(3):197-204. PubMed ID: 29556910
[TBL] [Abstract][Full Text] [Related]
27. Second primary cancers in breast cancer patients in Slovenia.
Volk N; Pompe-Kirn V
Cancer Causes Control; 1997 Sep; 8(5):764-70. PubMed ID: 9328199
[TBL] [Abstract][Full Text] [Related]
28. Risk for malignancies of infectious etiology among adult survivors of specific non-Hodgkin lymphoma subtypes.
Herr MM; Schonfeld SJ; Dores GM; Engels EA; Tucker MA; Curtis RE; Morton LM
Blood Adv; 2019 Jul; 3(13):1961-1969. PubMed ID: 31262739
[TBL] [Abstract][Full Text] [Related]
29. Risk of second non-hematological malignancies among 376,825 breast cancer survivors.
Brown LM; Chen BE; Pfeiffer RM; Schairer C; Hall P; Storm H; Pukkala E; Langmark F; Kaijser M; Andersson M; Joensuu H; Fosså SD; Travis LB
Breast Cancer Res Treat; 2007 Dec; 106(3):439-51. PubMed ID: 17277968
[TBL] [Abstract][Full Text] [Related]
30. Subsequent malignant neoplasms in the Childhood Cancer Survivor Study: Occurrence of cancer types in which human papillomavirus is an established etiologic risk factor.
Henderson TO; Fowler BW; Hamann HA; Nathan PC; Whitton J; Leisenring WM; Oeffinger KC; Neglia JP; Turcotte LM; Arnold MA; Conces MR; Howell RM; Robison LL; Armstrong GT; Alexander KA
Cancer; 2022 Jan; 128(2):373-382. PubMed ID: 34606625
[TBL] [Abstract][Full Text] [Related]
31. Second malignancies after adjuvant radiation therapy for early stage breast cancer: is there increased risk with addition of regional radiation to local radiation?
Hamilton SN; Tyldesley S; Li D; Olson R; McBride M
Int J Radiat Oncol Biol Phys; 2015 Apr; 91(5):977-85. PubMed ID: 25832690
[TBL] [Abstract][Full Text] [Related]
32. Risk of second non-breast cancer among patients treated with and without postoperative radiotherapy for primary breast cancer: A systematic review and meta-analysis of population-based studies including 522,739 patients.
Grantzau T; Overgaard J
Radiother Oncol; 2016 Dec; 121(3):402-413. PubMed ID: 27639892
[TBL] [Abstract][Full Text] [Related]
33. Risk of second primary cancer among women with breast cancer: a population-based study in Granada (Spain).
Molina-Montes E; Pollán M; Payer T; Molina E; Dávila-Arias C; Sánchez MJ
Gynecol Oncol; 2013 Aug; 130(2):340-5. PubMed ID: 23648471
[TBL] [Abstract][Full Text] [Related]
34. Association of First Primary Cancer With Risk of Subsequent Primary Cancer Among Survivors of Adult-Onset Cancers in the United States.
Sung H; Hyun N; Leach CR; Yabroff KR; Jemal A
JAMA; 2020 Dec; 324(24):2521-2535. PubMed ID: 33351041
[TBL] [Abstract][Full Text] [Related]
35. Declining second primary ovarian cancer after first primary breast cancer.
Schonfeld SJ; Berrington de Gonzalez A; Visvanathan K; Pfeiffer RM; Anderson WF
J Clin Oncol; 2013 Feb; 31(6):738-43. PubMed ID: 23284037
[TBL] [Abstract][Full Text] [Related]
36. Second Cancer Risk Up to 40 Years after Treatment for Hodgkin's Lymphoma.
Schaapveld M; Aleman BM; van Eggermond AM; Janus CP; Krol AD; van der Maazen RW; Roesink J; Raemaekers JM; de Boer JP; Zijlstra JM; van Imhoff GW; Petersen EJ; Poortmans PM; Beijert M; Lybeert ML; Mulder I; Visser O; Louwman MW; Krul IM; Lugtenburg PJ; van Leeuwen FE
N Engl J Med; 2015 Dec; 373(26):2499-511. PubMed ID: 26699166
[TBL] [Abstract][Full Text] [Related]
37. Risk of second malignant neoplasms after childhood leukemia and lymphoma: an international study.
Maule M; Scélo G; Pastore G; Brennan P; Hemminki K; Tracey E; Sankila R; Weiderpass E; Olsen JH; McBride ML; Brewster DH; Pompe-Kirn V; Kliewer EV; Chia KS; Tonita JM; Martos C; Jonasson JG; Merletti F; Boffetta P
J Natl Cancer Inst; 2007 May; 99(10):790-800. PubMed ID: 17505074
[TBL] [Abstract][Full Text] [Related]
38. The risk of a second primary lung cancer after a first invasive breast cancer according to estrogen receptor status.
Schonfeld SJ; Curtis RE; Anderson WF; Berrington de González A
Cancer Causes Control; 2012 Oct; 23(10):1721-8. PubMed ID: 22918549
[TBL] [Abstract][Full Text] [Related]
39. Second solid cancers after radiotherapy for breast cancer in SEER cancer registries.
Berrington de Gonzalez A; Curtis RE; Gilbert E; Berg CD; Smith SA; Stovall M; Ron E
Br J Cancer; 2010 Jan; 102(1):220-6. PubMed ID: 19935795
[TBL] [Abstract][Full Text] [Related]
40. Risk of subsequent primary oral cancer in a cohort of 69,460 5-year survivors of childhood and adolescent cancer in Europe: the PanCareSurFup study.
Sunguc C; Hawkins MM; Winter DL; Dudley IM; Heymer EJ; Teepen JC; Allodji RS; Belle FN; Bagnasco F; Byrne J; Bárdi E; Ronckers CM; Haddy N; Gudmundsdottir T; Garwicz S; Jankovic M; van der Pal HJH; Mazić MČ; Schindera C; Grabow D; Maule MM; Kaatsch P; Kaiser M; Fresneau B; Michel G; Skinner R; Wiebe T; Sacerdote C; Jakab Z; Gunnes MW; Terenziani M; Winther JF; Lähteenmäki PM; Zaletel LZ; Kuehni CE; Kremer LC; Haupt R; de Vathaire F; Hjorth L; Reulen RC
Br J Cancer; 2023 Jan; 128(1):80-90. PubMed ID: 36319851
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
